Beyond Type 1
Based in CA
🤖
AI Overview
With $0 in lobbying spend across 9 quarterly filings, Beyond Type 1 is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2022.
$0
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Insulin, diabetes, CGM, DSMT
- •Insulin affordability
- •Prescription drug affordability
- •Improving diabetes device access
- •Support for H.R.379 Improving Social Determinants of Health Act of 2021
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.